1. Home
  2. AIOT vs KALV Comparison

AIOT vs KALV Comparison

Compare AIOT & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PowerFleet Inc.

AIOT

PowerFleet Inc.

N/A

Current Price

$3.40

Market Cap

683.8M

ML Signal

N/A

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

N/A

Current Price

$17.36

Market Cap

757.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIOT
KALV
Founded
1993
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
683.8M
757.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
AIOT
KALV
Price
$3.40
$17.36
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$10.33
$30.00
AVG Volume (30 Days)
1.9M
554.3K
Earning Date
01-01-0001
04-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$50,000,000.00
Revenue This Year
$24.46
N/A
Revenue Next Year
$9.01
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
495.66
52 Week Low
$3.30
$9.83
52 Week High
$6.38
$19.00

Technical Indicators

Market Signals
Indicator
AIOT
KALV
Relative Strength Index (RSI) 32.00 66.30
Support Level N/A $14.45
Resistance Level $5.66 $19.00
Average True Range (ATR) 0.20 0.72
MACD 0.02 0.14
Stochastic Oscillator 20.45 78.38

Price Performance

Historical Comparison
AIOT
KALV

About AIOT PowerFleet Inc.

PowerFleet Inc is engaged in Internet-of-Things (IoT) solutions providing valuable business intelligence for managing high-value enterprise assets that improve operational efficiencies. It provide critical information that powers unified operations throughout organizations. It is solving the challenge of inefficient data collection, real-time visibility, and analysis that leads to transformative business operations. Its SaaS cloud-based applications take data from IoT devices and ecosystem of third-party and partner applications to present actionable information for customer.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: